Spotlight on Life Sciences Industry Report 2025 In pharmaphorum’s inaugural Life Sciences Industry Report 2025, delve into the trends that propelled the pharmaceutical industry along in 2024.
Market Access Sponsored Navigating Routes to Commercial Excellence in Cell and Gene ... 'Navigating Routes to Commercial Success in Cell and Gene Therapy', authored by Franjo Hanzl, VP, Business Development, Commercial at EVERSANA, Dr.
Debates & Insight Sponsored Pricing & Market Access Outlook 2015/2016 Edition Pricing and market access (P&MA) are key issues for the pharma industry as healthcare budgets continue to tighten and the value of innovative drugs, particularly in areas of high unmet need
Debates & Insight Sponsored Computer Gaming: The Future of Decision-Making for Life Scie... How can life science brands identify winning strategic decisions when there are so many variables to consider?
News Pfizer snaps up PD-1/VEGF drug from China's 3SBio Pfizer has joined the ranks of those developing cancer drugs that target PD-1 and VEGF, penning a $6bn licensing deal with China's 3SBio.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
